Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification-Reference-Cited by-同舟云学术

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Published:2018-03-22 Issue:2 Volume:170 Page:321-328
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Agersborg Sally,Mixon Christopher,Nguyen Thanh,Aithal Sramila,Sudarsanam Sucha,Blocker Forrest,Weiss Lawrence,Gasparini Robert,Jiang Shiping,Chen Wayne,Hess Gregory,Albitar Maher^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4755-5/fulltext.html

Reference36 articles.

1. Emde A, Köstler WJ, Yarden Y (2012) Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer. Crit Rev Oncol Hematol 84:e49–e57

2. Hilal T, Romond EH (2016) ERBB2 (HER2) testing in breast cancer. JAMA 315(12):1280–1281

3. Vogel CL, Cobleigh MA, Tripathy D et al (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20(3):719–726

4. Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353(16):1659–1672

5. Kaufman B, Trudeau M, Awada A et al (2009) Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2 + cohort in EGF103009, a phase II study. Lancet Oncol. 10(6):581–588

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The unique monoclonal antibodies and immunochemical assay for comprehensive determination of the cell-bound and soluble HER2 in different biological samples;Scientific Reports;2024-02-17

2. Immunocytochemical markers, molecular testing and digital cytopathology for aspiration cytology of metastatic breast carcinoma;Cytopathology;2023-11-20

3. Microswimmer-Assisted Dual-Signal Sensor for Multiple Targets in Whole Blood;Analytical Chemistry;2023-11-14

4. Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results;European Journal of Radiology;2023-10

5. Sandwich-type ultrasensitive immunosensing of breast cancer biomarker based on core-shell Au@PdAg dog-bone-like nanostructures and Au@PtRh nanorods;Sensors and Actuators B: Chemical;2023-05